Jin David 4
4 · Fortress Biotech, Inc. · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2024-04-01$1.70/sh+2,352$3,998→ 238,268 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Total holdings include 230,000 shares underlying deferred restricted stock units.